LENZ Therapeutics Inc (LENZ) — Cash Flow-to-Debt Ratio
Latest as of December 2025:
-1.53x
LENZ Therapeutics Inc (LENZ) has a Cash Flow-to-Debt Ratio of -1.53x as of December 2025, meaning its operating cash flow of $-33.02 Million could theoretically repay -2% of its total liabilities ($21.54 Million) in one year. See LENZ free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
-1.53x
Operating CF / Total Liabilities
Operating Cash Flow
$-33.02 Million
USD
Total Liabilities
$21.54 Million
USD
Data as of
Dec 2025
Most recent filing
LENZ Therapeutics Inc Cash Flow-to-Debt Ratio (2019–2025)
Historical debt coverage capacity for LENZ Therapeutics Inc across 7 annual periods. For the full cash flow conversion analysis, see LENZ cash flow metrics.
Annual Cash Flow-to-Debt Ratio for LENZ Therapeutics Inc (2019–2025)
Year-by-year debt coverage analysis for LENZ Therapeutics Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.21x | $-69.17 Million | $21.54 Million | ▲ +39.3% |
| 2024 | -5.29x | $-59.39 Million | $11.22 Million | ▼ -1329.7% |
| 2023 | -0.37x | $-60.38 Million | $163.09 Million | ▲ +70.1% |
| 2022 | -1.24x | $-87.98 Million | $71.12 Million | ▲ +23.8% |
| 2021 | -1.62x | $-52.85 Million | $32.55 Million | ▼ -502.6% |
| 2020 | -0.27x | $-8.72 Million | $32.36 Million | ▼ -3054.2% |
| 2019 | -0.01x | $-19.00K | $2.22 Million | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.